Patents by Inventor Marisa C. Yadon

Marisa C. Yadon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
    Publication number: 20180002298
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of tauopathies, such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, familial frontotemporal dementia/Parkinsonism linked to chromosome 17, amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.
    Type: Application
    Filed: April 27, 2017
    Publication date: January 4, 2018
    Inventors: LUKE A. ESPOSITO, MARISA C. YADON, JOEL CUMMINGS, F. MICHAEL HUDSON, THOMAS LAKE, QUBAI HU, JUDY CAM, ALAN D. SNOW
  • COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
    Publication number: 20170022174
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of tauopathies, such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, familial frontotemporal dementia/Parkinsonism linked to chromosome 17, amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.
    Type: Application
    Filed: May 10, 2016
    Publication date: January 26, 2017
    Inventors: LUKE A. ESPOSITO, MARISA C. YADON, JOEL CUMMINGS, F. MICHAEL HUDSON, THOMAS LAKE, QUBAI HU, JUDY CAM, ALAN D. SNOW
  • Compounds for the treatment of neurodegenerative diseases
    Patent number: 9334251
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of tauopathies, such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, familial frontotemporal dementia/Parkinsonism linked to chromosome 17, amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.
    Type: Grant
    Filed: June 16, 2015
    Date of Patent: May 10, 2016
    Assignee: PROTAMED, INC.
    Inventors: Luke A Esposito, Marisa C Yadon, Joel Cummings, F Michael Hudson, Thomas Lake, Qubai Hu, Judy Cam, Alan D Snow
  • Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies
    Patent number: 9169255
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of ?-amyloid diseases, such as observed in Alzheimer's disease and synucleinopathies, such as Parkinson's disease.
    Type: Grant
    Filed: October 10, 2012
    Date of Patent: October 27, 2015
    Assignee: Proteo Tech Inc.
    Inventors: Luke Esposito, Kelsey Hanson, Marisa C. Yadon, Thomas Lake, Alan D. Snow, Joel Cummings, Anil Kumar
  • Compounds for the treatment of Neurodegenerative Diseases
    Publication number: 20150274681
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of tauopathies, such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, familial frontotemporal dementia/Parkinsonism linked to chromosome 17, amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.
    Type: Application
    Filed: June 16, 2015
    Publication date: October 1, 2015
    Applicant: PROTEOTECH INC.
    Inventors: LUKE A. ESPOSITO, MARISA C. YADON, JOEL CUMMINGS, F. MICHAEL HUDSON, THOMAS LAKE, QUBAI HU, JUDY CAM, ALAN D. SNOW
  • Compounds for the treatment of neurodegenerative diseases
    Patent number: 9085549
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of synucleinopathies, such as Parkinson's disease and tauopathies.
    Type: Grant
    Filed: September 15, 2014
    Date of Patent: July 21, 2015
    Assignee: PROTEOTECH INC
    Inventors: Esposito A Luke, Marisa C Yadon, Joel Cummings, F Michael Hudson, Thomas Lake, Qubai Hu, Judy Cam, Alan D. Snow
  • Compounds for the treatment of neurodegenerative diseases
    Publication number: 20150011604
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of synucleinopathies, such as Parkinson's disease and tauopathies.
    Type: Application
    Filed: September 15, 2014
    Publication date: January 8, 2015
    Applicant: ProteoTech Inc.
    Inventors: Esposito A Luke, Marisa C Yadon, Joel Cummings, F Michael Hudson, Thomas Lake, Qubai Hu, Judy Cam, Alan D. Snow
  • Compounds for the treatment of neurodegenerative diseases
    Patent number: 8865754
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of synucleinopathies, such as Parkinson's disease and tauopathies.
    Type: Grant
    Filed: March 1, 2012
    Date of Patent: October 21, 2014
    Assignee: Proteotech Inc.
    Inventors: Luke A. Esposito, Marisa C. Yadon, Joel Cummings, F. Michael Hudson, Thomas Lake, Franz F. Hefti, Geoffrey Golding, Seok-Rye Choi, Ximin Li, Alan D. Snow, Qubai Hu, Judy Cam
  • CAFFEINATED COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES
    Publication number: 20140194447
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of ?-amyloid diseases, such as observed in Alzheimer's disease and synucleinopathies, such as Parkinson's disease.
    Type: Application
    Filed: October 10, 2012
    Publication date: July 10, 2014
    Inventors: Luke Esposito, Kelsey Hanson, Marisa C. Yadon, Thomas Lake, Alan D. Snow, Joel Cummings, Anil Kumar
  • COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
    Publication number: 20130338202
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of synucleinopathies, such as Parkinson's disease and tauopathies.
    Type: Application
    Filed: March 1, 2012
    Publication date: December 19, 2013
    Applicant: PROTEO TECH, INC
    Inventors: Luke A. Esposito, Marisa C. Yadon, Joel Cummings, F. Michael Hudson, Thomas Lake, Franz F. Hefti, Geoffrey Golding, Seok-Rye Choi, Ximin Li, Alan D. Snow, Qubai Hu, Judy Cam